Skip to content

Clinical trials

Phase 1/2 Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 1/2 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20033
20043
20052
20061
20073
20082
20091
20101
20112
20125
20132
20141
20165
20172
20182
20191
20203
20214
20224
20234
20241
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated16
Recruiting8
Active, not recruiting6
Unknown status6
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Beijing Biotech3
Pfizer3
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
National Cancer Centre, Singapore2
Valerio Therapeutics2
Vejle Hospital2
23andMe, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial71
Ovarian Neoplasms43
Fallopian Tube Neoplasms30
Breast Neoplasms17
Colorectal Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Endometrial Neoplasms7
Recurrence7
Triple Negative Breast Neoplasms7
Squamous Cell Carcinoma of Head and Neck6

Trials

Showing 26 to 50 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.